The Use of Dexamethasone in Maxillofacial Surgery: A Literature Review with Regard to the Ukrainian Experience

Authors

  • Ruslan Iakymenko Private Higher Education Institution 'University of Medicine and Social Sciences', Kharkiv, Ukraine
  • Oleg Savchuk PJSC 'University 'Interregional Academy of Personnel Management', Kyiv, Ukraine
  • Rostyslav Stupnytskyi Kyiv International University, Kyiv, Ukraine
  • Mykyta Lobur Bogomolets National Medical University, Kyiv, Ukraine
  • Artem Lutsenko Bogomolets National Medical University, Kyiv, Ukraine

DOI:

https://doi.org/10.33295/1992-576X-2026-3-MFSD-1

Keywords:

dexamethasone, dental implant, postoperative pain, swelling, trismus, glucocorticoids

Abstract

Objective — to conduct a systematic analysis of evidence-based data regarding the effectiveness and safety of dexamethasone in the perioperative management of dental implantation.

Materials and Methods. A literature search was conducted across PubMed, Scopus, Cochrane Library, and Google Scholar for the period 2013–2024 using the keywords: dexamethasone, dental implant, postoperative pain, swelling, trismus, glucocorticoids. Analyzed parameters included dosages (1–8 mg), routes of administration (oral, intramuscular, intravenous, submucosal, topical), visual analog scale (VAS) pain scores, swelling volume, degree of trismus, and the frequency of adverse events.

Results and Discussion. Dexamethasone reduced pain intensity by 30–45%, swelling by 25–43%, and trismus by ~30%. The greatest effect was observed with preoperative administration of 4–8 mg 30–60 minutes prior to implantation. Adverse events were minor (3–5% of cases) and predominantly presented as transient hyperglycemia in patients with diabetes mellitus. Ukrainian clinical data confirm the feasibility of short-term dexamethasone regimens with no negative impact on osteogenesis.

Conclusions. Dexamethasone is an effective, safe, and pathogenetic-based component of pharmacological support in dental implantation. A single preoperative dose of 4 mg is optimal for most patients. Conducting Ukrainian multicenter randomized controlled trials (RCTs) is recommended to standardize relevant protocols.

Downloads

Download data is not yet available.

Author Biographies

Ruslan Iakymenko, Private Higher Education Institution 'University of Medicine and Social Sciences', Kharkiv, Ukraine

PhD, Associate Professor, Department of Dentistry

Oleg Savchuk, PJSC 'University 'Interregional Academy of Personnel Management', Kyiv, Ukraine

Doctor of Medical Sciences, Professor, Dean of the Faculty of Medicine and Dentistry

Rostyslav Stupnytskyi, Kyiv International University, Kyiv, Ukraine

Doctor of Medical Sciences, Professor, Vice-Rector for Academic and Scientific Work and Innovative Development of Medicine

Mykyta Lobur, Bogomolets National Medical University, Kyiv, Ukraine

higher education student at the National Institute of Dentistry

Artem Lutsenko, Bogomolets National Medical University, Kyiv, Ukraine

higher education student at the National Institute of Dentistry

References

Falci, S. G. M., Lima, T. C., Martins, C. C., Santos, C. R. R., & Pinheiro, M. L. P. (2017). Preemptive effect of dexamethasone in third-molar surgery: a meta-analysis. Anesthesia Progress, 64(3), 136–143. DOI: https://doi.org/10.2344/anpr-64-05-08

Kim, C.-Y., Choi, Y.-S., & Lee, J.-H. (2018). Effect of dexamethasone on postoperative discomfort after dental implant placement. Journal of Oral and Maxillofacial Surgery, 76(8), 1675–1681. DOI: https://doi.org/10.1016/j.joms.2018.03.036

Aghaloo, T., & Moy, P. K. (2020). Corticosteroids in oral surgery: a systematic review. International Journal of Oral & Maxillofacial Implants, 35(5), 927–935.

Dionne, R. A., Gordon, S. M., Rowan, J., Kent, M. L., & Brahim, J. S. (2003). Dexamethasone efficacy in reducing postsurgical sequelae of removal of impacted third molars. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, 95(4), 382–388.

Isola, G., Matarese, G., Ramaglia, L., Cicciù, M., & Matarese, M. (2022). Topical dexamethasone in dental surgery: a randomized clinical trial. Clinical Oral Investigations, 26(2), 1345–1352. DOI: https://doi.org/10.1007/s00784-021-04244-6

Jena, S. S., Mishra, S., Mishra, N., et al. (2020). Effect of preoperative dexamethasone on postoperative pain and swelling following implant surgery. Journal of Oral Implantology, 46(4), 317–323. DOI: https://doi.org/10.1563/aaid-joi-D-19-00215

Kalita, S., Goyal, R., Kumar, H., et al. (2024). Efficacy of dexamethasone in reducing postoperative symptoms of the surgical extraction of impacted third molars. Cureus, 16(10), e72035. DOI: https://doi.org/10.7759/cureus.72035

Lau, A. A. L., Yuen, K. Y., Zheng, L., et al. (2021). Third molar surgery outcomes: a randomized clinical trial comparing submucosal and intravenous dexamethasone. Journal of Oral and Maxillofacial Surgery, 79(2), 295–304. DOI: https://doi.org/10.1016/j.joms.2020.09.020

Fernández-Martín, U., Lisbona-González, M. J., Vallecillo-Rivas, M., et al. (2024). Dexamethasone vs. methylprednisolone in impacted lower third molar surgery: randomized controlled clinical trial. Journal of Clinical Medicine, 13(16), 4614. DOI: https://doi.org/10.3390/jcm13164614

Sabhlok, S., Kenjale, P., Mony, D., et al. (2015). Randomized controlled trial to evaluate the efficacy of oral dexamethasone and intramuscular dexamethasone in mandibular third molar surgeries. Journal of Clinical and Diagnostic Research, 9(11), ZC48–ZC51. DOI: https://doi.org/10.7860/JCDR/2015/13930.6813

Saiid Elshafey Mohamed Beshir. (2025). Corticosteroids in impacted mandibular third molar surgery: a narrative review. Bulletin of Stomatology and Maxillofacial Surgery, 21(5), 5–11. DOI: https://doi.org/10.58240/1829006X-2025.21.5-5

Messer, E. J., & Keller, J. J. (1975). The use of intraoral dexamethasone after extraction of mandibular third molars. Oral Surgery, Oral Medicine, Oral Pathology, 40(5), 594–598. DOI: https://doi.org/10.1016/0030-4220(75)90369-2

Logvynenko, I., Dakhno, L., & Bursova, V. (2025). Effectiveness of topical application with dexamethasone during sagittal split osteotomy of the mandible in minimising clinical symptoms of postoperative neurosensory disorders. BMC Surgery, 25(1), 76. DOI: https://doi.org/10.1186/s12893-025-02803-1

Ohonovskyi, R. Z., Khomych, N. M., & Kuzniak, N. B. (2014). Treatment of inflammatory complications after atypical removal of lower third molars: a literature review (part 1). Bulletin of Problems of Biology and Medicine, 1(106), 18–23. [Огоновський Р. З., Хомич Н. М., Кузняк Н. Б. (2014). Лікування запальних ускладнень після атипового видалення нижніх третіх молярів: огляд літератури (частина 1). Вісник проблем біології і медицини, 1(106), 18–23] [in Ukrainian].

Hudzan, Ya. S. (2023). Reconstructive and rehabilitative treatment of patients with total edentulism [Dissertation]. Danylo Halytsky Lviv National Medical University. [Гудзан Я. С. (2023). Реконструктивно-реабілітаційне лікування пацієнтів із повною відсутністю зубів [Дисертація]. Львівський національний медичний університет імені Данила Галицького]. [in Ukrainian].

Bureha, Yu. O., Loban, H. A., & Fedorchenko, V. I. (2016). Dentistry: teaching manual. Zaporizhzhia State Medical University. [Бурега Ю. О., Лобань Г. А., Федорченко В. І. (2016). Стоматологія: навчальний посібник. Запорізький державний медичний університет] [in Ukrainian].

Published

2026-07-30

How to Cite

Iakymenko Р., Savchuk О., Stupnytskyi Р., Lobur М., & Lutsenko А. (2026). The Use of Dexamethasone in Maxillofacial Surgery: A Literature Review with Regard to the Ukrainian Experience. Actual Dentistry, (3). https://doi.org/10.33295/1992-576X-2026-3-MFSD-1

Issue

Section

MAXILLOFACIAL SURGERY AND SURGICAL DENTISTRY